Evidence map›Paper›PMID 37760124›Full record

ArticleBioengineering (Basel, Switzerland)2023

Technical Evaluation of a New Medical Device Based on Rigenase in the Treatment of Chronic Skin Lesions.

Eugenia Romano, Claudio Campagnuolo, Roberta Palladino, Giulia Schiavo, Barbara Maglione, Cristina Luceri, Natascia Mennini

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Evaluation of Biological Effect ofAdvances in pharmacological and pharmaceutical sciences · 2026
    Article
  4. Article
  5. Bioactive Dressing: A New Algorithm in Wound Healing.Journal of clinical medicine · 2024
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eugenia RomanoFarmaceutici Damor S.p.A., Via E. Scaglione 27, 80125 Napoli, Italy.
Claudio CampagnuoloFarmaceutici Damor S.p.A., Via E. Scaglione 27, 80125 Napoli, Italy.
Roberta PalladinoFarmaceutici Damor S.p.A., Via E. Scaglione 27, 80125 Napoli, Italy.
Giulia SchiavoFarmaceutici Damor S.p.A., Via E. Scaglione 27, 80125 Napoli, Italy.ORCID 0000-0002-0579-4845
Barbara MaglioneFarmaceutici Damor S.p.A., Via E. Scaglione 27, 80125 Napoli, Italy.
Cristina LuceriDipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, 50019 Sesto Fiorentino, Italy.ORCID 0000-0003-1232-8778
Natascia MenniniDipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, 50019 Sesto Fiorentino, Italy.ORCID 0000-0002-2439-2251
Farmaceutici Damor (Italy) · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wound is characterized by slow healing time, persistence, and abnormal healing progress. Therefore, serious complications can lead at worst to the tissue removal. In this scenario, there is an urgent need for an ideal dressing capable of high absorbency, moisture retention and antimicrobial properties. Herein we investigate the technical properties of a novel advanced non-woven triple layer gauze imbibed with a cream containing Rigenase, an aqueous extract of

Indexed as

chronic wound healingRigenaseskin injuriesTriticum vulgare aqueous extractwound dressing

Identifiers

PMID37760124
PMCPMC10526047
OpenAlexW4386282874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.